Tesamorelin
A GHRH analog peptide with a visceral fat focus. Tesamorelin signals the pituitary to release growth hormone in natural pulses, with the strongest clinical evidence among GHRH peptides for reducing visceral adipose tissue. Serving Lisle, Naperville & Chicago’s western suburbs.
Book a ConsultationWhat is Tesamorelin?
A GHRH analog peptide with a visceral fat focus.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). Like Sermorelin, it signals the pituitary to release the body’s own growth hormone in natural overnight pulses, rather than supplying growth hormone directly. The difference is that tesamorelin is longer-acting and more potent, and it carries the strongest published evidence base among GHRH analogs for one specific outcome: reducing visceral adipose tissue (VAT), the deep abdominal fat that sits around organs.
Tesamorelin is FDA-approved for HIV-associated lipodystrophy under the brand Egrifta. It is not a weight loss drug like a GLP-1 — it is a body-composition tool that works through growth hormone signaling, with research protocols typically using evening dosing in cycles.
- + Strongest GHRH-analog evidence for visceral fat reduction
- + Works through the body’s own GH pulses, feedback loops intact
- + Longer-acting and more potent than Sermorelin
- + FDA-approved (Egrifta) for HIV lipodystrophy, off-label otherwise
- + Pairs naturally with training and nutrition, not GLP-1 replacement
What tesamorelin may support.
Visceral Fat Reduction
Research suggests tesamorelin reduces visceral adipose tissue (VAT) more effectively than other GHRH analogs. The strongest evidence base comes from clinical trials in HIV-associated lipodystrophy, where tesamorelin was shown to selectively lower VAT over a 26-week course. That mechanism is why it’s used off-label as a body-composition tool with a visceral fat focus.
- Strongest GHRH-analog evidence for VAT
- Body composition focus, not total weight
- Evaluated over cycles, not weeks
Lean Body Composition
Alongside visceral fat reduction, GH pulses may support lean mass preservation over a cycle. Results tend to compound when paired with resistance training and adequate protein. Tesamorelin is best thought of as a body-composition tool that works with your training, not in place of it. Personal training pairs naturally.
- May support lean mass alongside fat loss
- Best paired with resistance training
- Hedged claim. Outcomes vary
Sleep & Recovery
Like other GHRH analogs, evening dosing aligns with the body’s natural overnight growth hormone cycle. Many clients notice sleep quality changes first, with recovery from training following over the weeks after. The data on sleep is less specific to tesamorelin than to GHRH signaling broadly, so we frame it as a likely supportive effect, not a primary indication.
- Evening dosing matches the natural GH pulse
- Sleep often shifts before body composition
- Recovery typically tracks with the same change
A note on honesty: tesamorelin’s evidence base sits in HIV lipodystrophy, with off-label use for body composition. We’ll tell you what the research supports and what it doesn’t. Book a free consult →
How tesamorelin compares.
Tesamorelin
Longer half-life and stronger pituitary stimulation than other GHRH analogs. Carries the strongest peer-reviewed evidence for visceral adipose tissue reduction, with FDA approval (as Egrifta) in HIV-associated lipodystrophy. Used off-label for body-composition goals.
- · Strongest GHRH evidence for visceral fat
- · Longer-acting and more potent
- · Body composition focus, not total weight
- · Typically run in cycles, then evaluated
Sermorelin & Other GHRH Analogs
Shorter-acting GHRH analogs like Sermorelin work through the same pathway with a gentler signal. They’re often a better starting point for general longevity, sleep, and recovery goals, where a strong visceral-fat focus isn’t the priority.
- · Gentler GHRH signal
- · Often a sensible starting point
- · Sleep, recovery, general longevity
- · Less specific visceral-fat evidence
Choosing between them: if visceral fat and body composition are the priority, tesamorelin is usually the stronger fit. If the goal is broader longevity, sleep, and recovery support, Sermorelin is often a more sensible starting point. For a wider view, read the peptide therapy overview. And if total weight loss is the real goal, see our weight loss protocols, which use GLP-1s rather than GHRH peptides.
Common Questions
Everything you need to know about tesamorelin at Defiant in Lisle, IL. Serving Naperville and Chicago’s western suburbs.
Considering tesamorelin?
Free consultation. We’ll walk through what the research supports, whether tesamorelin is the right fit (or whether Sermorelin or a weight loss protocol would be a better starting point), and how it slots into the rest of your peptide therapy. Bring your questions.
Book a Consultation